Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Acarix AB: Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor System in U.S. Emergency Departments | 80 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor®... ► Artikel lesen | |
16.06. | Acarix AB: Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD | 106 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at... ► Artikel lesen | |
12.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2025 | 153 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The report highlights continued growth in the U.S.... ► Artikel lesen | |
13.02. | Acarix Publishes Year-End Report 2024 - Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts | 238 | PR Newswire | OKLAHOMA CITY, Feb. 13, 2025 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues... ► Artikel lesen | |
07.11.24 | Acarix AB: Acarix Publishes Third Quarter 2024 Report | 151 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 2024. The company has made significant progress toward operational... ► Artikel lesen | |
22.08.24 | Acarix AB (publ) publishes Interim Report, April - June 2024 | 238 | PR Newswire | NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved... ► Artikel lesen | |
ACARIX Aktie jetzt für 0€ handeln | |||||
15.07.24 | Acarix Shares Begin Trading on the US-based OTCQB Market | 189 | PR Newswire | NEW YORK, July 15, 2024 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
CARL ZEISS MEDITEC | 57,00 | +1,06 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen | |
ECKERT & ZIEGLER | 67,85 | +2,03 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
UNITEDHEALTH | 263,95 | -0,02 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
HIMS & HERS HEALTH | 42,410 | +0,43 % | Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose! | © Foto: Christian Schultz/dpaNovo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims... ► Artikel lesen | |
BICO GROUP | 3,210 | -0,25 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
NUGEN MEDICAL DEVICES | 0,033 | -5,75 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
SPINEWAY | 0,118 | -1,67 % | Spineway: Minutes of the General Meeting of June 4, 2025 | Press release Ecully, June 6, 2025 - 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
UNIDOC HEALTH | 0,123 | -8,92 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
VERU | 0,565 | +9,51 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
CLARIANE | 5,115 | +1,09 % | Clariane has successfully completed a bond issue of 400 million euros | ||
SENSEONICS | 0,446 | +5,64 % | Senseonics lays out hopes for next-gen CGM commercial timelines | ||
BONESUPPORT | 25,760 | 0,00 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
VIROMED MEDICAL | 4,200 | -2,33 % | EQS-News: Viromed Medical AG: Kaltplasma-Technologie zeigt Potenzial zur signifikanten Reduktion von Todesfällen bei beatmeten Patienten | EQS-News: Viromed Medical AG
/ Schlagwort(e): Studie/Sonstiges
Viromed Medical AG: Kaltplasma-Technologie zeigt Potenzial zur signifikanten Reduktion von Todesfällen bei beatmeten... ► Artikel lesen |